Mantle Cell Lymphoma (MCL) Part One: Treatment Advances
The Bloodline with Blood Cancer United Podcast
Audio is streamed directly from the publisher (media.blubrry.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Join us as we speak to Dr. Benjamin Lampson of Dana-Farber Cancer Institute in Boston, MA. In Part One of this two-part series on mantle cell lymphoma (MCL), Dr. Lampson discusses the latest treatment advances for MCL. With more treatments available than just a few years ago, Dr. Lampson shares how his conversations with his patients have changed, providing more hope after a diagnosis of MCL.
Be sure to tune into Part 2 launching on May 23, 2022, where Dr. Lampson will focus on the exciting possibilities of CAR T-cell therapy for MCL.
CLICK HERE to participate in our episode survey.Mentioned on this episode:
- Mantle Cell Lymphoma
- Mantle Cell Mantle Cell Lymphoma (MCL) with Dr. Benjamin Lampson: What Patients Should Know episode
- LLS COVID Antibody Study and COVID resources
- Protecting Patients: COVID and Vaccine Updates episode
- Stem Cell Transplant
- Autologous Stem Cell Transplant
- Allogeneic Stem Cell Transplant
- Graft-vs-Host Disease
- Highlights from ASH conference
Additional LLS Support Resources:
- Information Specialists
- Financial support
- Free telephone/web patient programs
- Patti Robinson Kaufmann First Connection Program
- Free booklets
- LLS Public Policy & Advocacy
- Clinical Trial Support Center
- Online chats
- Caregiver support
- LLS Community
- Support groups
- Free Nutrition Consultations
- LLS Advocacy
- Survivorship Workbook
Support for this episode provided by Eli Lilly & Company.
The post Mantle Cell Lymphoma (MCL) Part One: Treatment Advances first appeared on The Bloodline with Blood Cancer United Podcast.